111, Inc. (YI) – Company Press Releases
-
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow
-
111 Announces Receipt of Withdrawal of Going Private Proposal
-
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
-
111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow
-
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results
-
111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow
-
111, Inc. Announces First Quarter 2023 Unaudited Financial Results
-
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow
-
111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results
-
111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow
-
111, Inc. Hosts Hua Medicine Launches First Official Flagship Store
-
111, Inc. Announces Third Quarter 2022 Unaudited Financial Results
-
111 to Announce Third Quarter 2022 Unaudited Financial Results on December 1, 2022 - Conference Call to Follow
-
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
-
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
-
111, Inc. Announces Second Quarter 2022 Unaudited Financial Results
-
111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow
-
111, Inc. Announces First Quarter 2022 Unaudited Financial Results
-
111 to Announce First Quarter 2022 Unaudited Financial Results on June 16, 2022 - Conference Call to Follow
-
111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act
-
111, Inc. Provides Urgently-needed Items and Online Services to Support Shanghai's Fight Against Covid-19 Pandemic
-
111, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results
-
111, Inc. Becomes First Online Retail Platform for BGI's SARS-CoV-2 Virus Antigen Detection Kits
-
111, Inc. Reaches Strategic Partnership on Direct Supply with Beilin Pharmaceutical to Blaze New Trails in Digital Development of Chinese Patent Medicine
-
111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow
-
Harbour BioMed Appoints Mr. Weihao Xu as Chief Strategy Officer
-
111, Inc. Announces Third Quarter 2021 Unaudited Financial Results
-
/C O R R E C T I O N -- 111, Inc./
-
111 to Announce Third Quarter 2021 Unaudited Financial Results on November 19, 2021 - Conference Call to Follow
-
111, Inc. Announces Strategic Partnership with Chugai Pharma China Co., Ltd. to Accelerate Innovations in Chronic Disease Management
-
111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference
-
111, Inc. Announces $10 Million Share Repurchase Program
-
111, Inc. Announces Second Quarter 2021 Unaudited Financial Results
-
111, Inc. Deepens Partnership with Bayer Healthcare
-
111 to Announce Second Quarter 2021 Unaudited Financial Results on August 27, 2021 -Conference Call to Follow
-
111, Inc. Enters into Strategic Cooperation Agreement with Zelgen to Develop a New Management Platform for Liver Cancer Patients in China
-
BioDuro-Sundia Strengthens Leadership with New CFO and Operations SVP
-
111, Inc. Announces First Quarter 2021 Unaudited Financial Results
-
111 to Announce First Quarter 2021 Unaudited Financial Results on May 19, 2021 - Conference Call to Follow
-
111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform
-
111, Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results
-
111, Inc. Enters into First-Ever Strategic Partnership with BeiGene
-
111, Inc. Achieves Full Distribution Coverage Across Mainland China with the Opening of Two Key Fulfillment Centers
-
111 to Announce Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results on March 18, 2021
-
111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services
-
111, Inc. Announces Additional Round of New Capital Injection
-
CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer
-
111, Inc. Announces Third Quarter 2020 Unaudited Financial Results
-
111 to Announce Third Quarter 2020 Unaudited Financial Results on November 19, 2020
Back to YI Stock Lookup